![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Spectrum Pharmaceuticals Acquires Talon Therapeutics
17 juil. 2013 07h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 17, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI) entered into an...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results
15 mai 2013 17h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the three months ended March 31, 2013.
Corporate...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results
01 avr. 2013 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., April 1, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the fourth quarter and year ended December 31, 2012.
2012...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics to Host a Conference Call to Report 2012 Financial Results and Business Update on April 1, 2013
19 mars 2013 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 19, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) will host a conference call on Monday, April 1, 2013 at 9:00AM PDT, to discuss 2012 financial...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Announces Review of Strategic Alternatives
07 janv. 2013 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Appoints Elizabeth Weatherman to Board of Directors
04 janv. 2013 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Marqibo(R) Data to be Presented in Three Scientific Sessions and at a Product Theater During the American Society of Hematology Annual Meeting
05 déc. 2012 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), an oncology and oncology supportive care focused biopharmaceutical company, today announced that...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics Announces Publication of the Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) RALLY Study in the Journal of Clinical Oncology (JCO)
27 nov. 2012 09h00 HE
|
Talon Therapeutics, Inc.
Data supported FDA accelerated approval of Marqibo (http://jco.ascopubs.org/)
Data published online ahead of print as a Rapid Communication
Data represents the per protocol, planned...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics, Inc. Reports Third Quarter 2012 Financial Results
14 nov. 2012 09h00 HE
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and nine months ended September 30, 2012.
"FDA...
![Talon Therapeutics, Inc. Logo](/news-release/logo/214358/0/214358.jpg?lastModified=12%2F09%2F2016%2022%3A40%3A02&size=2)
Talon Therapeutics' Recently Approved Marqibo Presented at 2012 Chemotherapy Foundation Symposium
13 nov. 2012 12h44 HE
|
Talon Therapeutics, Inc.
"The Role of Vincristine Sulfate Liposome Injection in Hematologic Malignancies Data" presented by Dr. Dan Douer of Memorial Sloan-Kettering on Nov. 7
Marqibo is indicated for the treatment...